A more effective product with less side effects than tamiflu and only 2% of the market, GSK will have to pay up bigtime.
- Forums
- ASX - By Stock
- BTA
- 2% market share
2% market share
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BTA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
1CG
ONE CLICK GROUP LIMITED
Mark Waller, MD
Mark Waller
MD
Previous Video
Next Video
SPONSORED BY The Market Online